eli lilly and tirzepatide Lilly's Weight-Loss Drugs Zepbound, Mounjaro No Longer in Shortage, FDA Says FDA approval for Zepbound (tirzepatide)

Published data from tirzepatide withdrawal studies indicate that a significant proportion of lost weight is regained within 12 months of stopping treatment, consistent with the broader pattern observed across the GLP-1 class

Mechanism: Once in your system, exenatide acts like GLP-1, triggering insulin release when your blood sugar is high, slowing down your stomach emptying and nudging your brain to feel full sooner

Post-meal glucose spikes become more pronounced as the immediate insulin response weakens

Dont wait, your healthier future starts here

But if we do some quick calculations, if everyone who was obese in the US went on Wegovy, someone would have to foot a bill of $3 trillion per year